Climax John Dr Insider Trades & Stock Holdings
Climax John Dr, Director at ICON Public Limited Company has 1 Form 4 trade on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($875.88K), net -$875.88K. Latest filing: disposed of 5K shares of $ICLR on Sep 16, 2026 at $175.
- Trades on file
- 1
- Open-market bought
- $0
- Open-market sold
- $875.88K
- Net open-market
- -$875.88K
- Latest filing
- Sep 16, 2026
All insider trades by Climax John Dr
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ICLR | Sell (Open-market sale) | 5K | $175 | $875.88K | -5.8% | -2.2% | Director | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Climax John Dr traded
Frequently asked questions
Has Climax John Dr been buying or selling stock?
Climax John Dr has 0 open-market purchases and 1 open-market sale on file, net -$875.88K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Climax John Dr's latest insider trade?
disposed of 5K shares of $ICLR on Sep 16, 2026 at $175.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.
SMS Terms
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.